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SUMMARY
There is a growing consensus that Alzheimer’s dis-
ease (AD) involves failure of the homeostatic machin-
ery, which underlies the firing stability of neural
circuits. What are the culprits leading to neuron firing
instability? The amyloid precursor protein (APP) is
central to AD pathogenesis, and we recently showed
that its intracellular domain (AICD) could modify syn-
aptic signal integration. We now hypothesize that
AICD modifies neuron firing activity, thus contrib-
uting to the disruption of memory processes. Using
cellular, electrophysiological, and behavioral tech-
niques, we show that pathological AICD levels
weaken CA1 neuron firing activity through a gene-
transcription-dependent mechanism. Furthermore,
increased AICD production in hippocampal neurons
modifies oscillatory activity, specifically in the g-fre-
quency range, and disrupts spatial memory task.
Collectively, our data suggest that AICD pathological
levels, observed in AD mouse models and in human
patients, might contribute to progressive neuron ho-
meostatic failure, driving the shift from normal aging
to AD.
INTRODUCTION
Alzheimer’s disease (AD) is an incurable neurodegenerative dis-
order, with increasing prevalence in aging populations. Almost
two decades ago, Selkoe (2002) convincingly proposed that
AD begins with subtle alterations at the synapse leading to syn-
aptic failure. Yet, could synaptic modifications alone account for
the collapse of neural networks stability? Currently, there is a
growing consensus that AD results from the failure of the homeo-
static machinery, which underlies the firing stability of neural cir-
cuits, hence precipitating an imbalance between neuron firing
stability and synaptic plasticity (De Strooper and Karran, 2016;
Frere and Slutsky, 2018). Indeed, whole-head magnetoenceph-
alography (MEG) studies show alterations in firing synchroniza-
tion at gamma (30–80 Hz) frequencies in AD patients and AD
mouse models (Gillespie et al., 2016; Palop et al., 2007; Stam
et al., 2002; Verret et al., 2012). The molecular mechanisms un-
derlying these neuron firing modifications remain to be clearly
elucidated.
Human genetic evidence indicates that the amyloid precursor
protein (APP) is central to the pathogenesis of AD (Jonsson et al.,
2012; van der Kant and Goldstein, 2015). Comprehensive char-
acterization of mutant APP-overexpressing transgenic mice
have reported changes of firing homeostasis in both excitatory
and inhibitory neurons of the hippocampus (Brown et al., 2011;
Hazra et al., 2013; Kaczorowski et al., 2011; Kerrigan et al.,
2014; Minkeviciene et al., 2009; Wykes et al., 2012), the entorhi-
nal cortex (Marcantoni et al., 2014), the cortex (Hazra et al., 2013;
Verret et al., 2012), and the cerebellum (Hoxha et al., 2012), but
the entities behind these firing modifications are yet to be iden-
tified. In these models, the contribution of individual peptides
generated from abnormal or enhanced proteolytic APP cleavage
cannot be dissociated. Approaches allowing to decipher the
contribution of individual APP fragments to the modulation of
neuron firing, are thus needed and will be crucial to fully under-
stand the complexity of AD pathogenesis.
We and others have shown that the APP intracellular domain
(AICD) is increased in the brain of AD patients and animal models
(Ghosal et al., 2009; Lauritzen et al., 2012; Pousinha et al., 2017).
Given its impact on nuclear signaling (Bukhari et al., 2017), AICD
stands as a key APP fragment to shape cellular functions. Of
note, this APP fragment has been linked to the neuron homeo-
static machinery as AICD was shown to modulate intracellular
calcium homeostasis (Hamid et al., 2007; Leissring et al.,
2002), and destabilization of intracellular calcium is a key factor
leading to neuronal intrinsic excitability disruption (Zhang and
Linden, 2003). Notably, both AICD lack of expression (Ghosal
et al., 2009; Klevanski et al., 2015) and overexpression (Ghosal
et al., 2009) lead to memory deficits. Together, these data sug-
gest that an imbalance in AICD levels, and therefore function,
has detrimental cellular impact and could thus contribute to AD
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pathogenesis. We here asked whether pathological levels of
AICD could affect neuron firing and oscillatory activity, thus
contributing to the disruption of memory processes.
RESULTS
AICD Weakens CA1 Pyramidal Neuron Firing in the g
Frequency Range through a Gene-Transcription-
Dependent Mechanism
First, we examined the impact of AICD on neuron firing activity.
We increased intracellular AICD levels by using in vivo transduc-
tion of neurotropic recombinant adeno-associated viruses
(AAVs) encoding AICD (Figures 1A and 1B), as described in detail
in Pousinha et al. (2017). Briefly, the human AICD c-DNA
sequence (last 50 amino acids of APP) was inserted in an AAV
vector also expressing GFP (called hereafter AICD virus). We
also created AAVs expressing AICD coupled to a nuclear locali-
zation signal (NLS) (AICDnls virus) or coupled to a nuclear export-
ing signal (NES) (AICDnes virus) to allow discrimination between
the nuclear versus cytoplasmatic roles of AICD. The AAV vector
expressing only GFP was used as control (GFP virus) (Fig-
ure S1A). Whole-cell current-clamp recordings of CA1 pyramidal
cells transduced with different virus (AICD, AICDnls, AICDnes, and
GFP) were performed (Figures 1A and 1B). No alterations were
observed regarding the restingmembrane potential (Figure S1B),
nor the membrane input resistance (Figures S1C–S1E). In order
to study supra-threshold CA1 pyramidal cells properties in the
transduced neurons, 200-ms depolarizing current pulses, incre-
menting in steps of 50 pA, were applied at a pre-stimulus
potential fixed at!65 mV and AP firing properties were analyzed
(Figure 1C). As illustrated (Figure 1D), when a current injection of
300 pA was applied, AICD or AICDnls neurons fired at a lower fre-
quency than GFP or AICDnes neurons, a difference that was sys-
tematically observed for current injections higher than 300 pA.
Thus, increased levels of AICD disrupt firing activity at the
gamma-frequency range. Moreover, this effect likely requires
AICD presence in the nucleus as neurons transduced with
AICDnes behaved like GFP neurons.
Spike-frequency adaptation is a property of many neurons
defined as a decreasing rate of action potential (AP) firing during
prolonged excitation. This mechanism has been shown to play
roles in perceptual processing and learning (Benda et al., 2005;
Moyer et al., 2000; Peron andGabbiani, 2009). To better evaluate
the ability of AICD neurons to adapt their firing behavior with
time, we measured the firing adaptation ratio for I = 500 pA in
the transduced neurons. As shown (Figure 1E), AICD or AICDnls
neurons present higher firing adaptation than GFP neurons
("40% higher). Importantly, AICDnes neurons showed similar
firing adaptation ratio to GFP neurons pointing again for a nu-
clear role of AICD in this phenotype. Further analysis of AP shape
and AP adaptation was performed in order to access the cellular
mechanism linked to the AICD effect on neuron intrinsic excit-
ability. Using phase-plane plots of dV/dt versus V for the first
and last APs of trains generated during 500-pA current steps
(Figure S2), we estimated the average dV/dtmax as an indication
of the maximal Na+ current contributing to the AP (Colbert et al.,
1997; Marcantoni et al., 2014) and the voltage at which dV/dtmax
is 4% of its maximum as the threshold potential of AP generation
(Bean, 2007). As shown in Figure S2, these parameters were
similar in GFP, AICD, and AICDnls neurons. We therefore
conclude that the Na+ channels responsible for AP generation
are not implicated in the AICD-dependent alteration of neuronal
excitability.
To confirm our finding and exclude putative overexpression-
related artifacts of virus-mediated in vivo expression, we used
an alternative approach; i.e., we provided ex vivo intracellular de-
livery of AICD. We synthesized peptides representing AICDnls or
a negative scrambled control peptide (scrAICDnls) linked at the
N terminus to the cell-penetrating domain TAT (Guscott et al.,
2016). We pre-incubated hippocampal slices with a dose of
TAT-AICDnls (100 nM), shown to induce an AICD intracellular in-
crease in the range of values observed in an AD mouse model
(Pousinha et al., 2017). Importantly, in this previous work, we
confirmed that TAT-AICDnls is enriched in the nucleus (Pousinha
et al., 2017). Consistent to what we observedwith 2weeks in vivo
expression of virally encoded AICD, ex vivo delivery of 100 nM
TAT-AICDnls reduced the firing frequency of CA1 pyramidal cells,
an effect that was not observed with incubation of 100 nM con-
trol peptide (TAT-scrAICDnls; Figure 1F). Furthermore, ex vivo de-
livery of AICD engages the same cellular mechanisms as in vivo
virus-mediated AICD expression, as spike-frequency adaptation
(Figure 1G) was increased in neurons from slices pre-incubated
with TAT-AICDnls (100 nM). Since the data obtained by using
in vivo AICD intracellular increase pointed for a nuclear AICD-
dependent mechanism, we examined the firing frequency prop-
erties of neurons from slices pre-incubated with TAT-AICDnls or
TAT-scrAICDnls in presence of the inhibitor of gene transcription,
actinomycin (25 mM). Actinomycin was added during both TAT
peptides incubation and bath perfusion of slices. As shown (Fig-
ure 1H), TAT-AICDnls failed to alter the neuronal firing frequency
in the presence of this inhibitor, confirming a transcription-
dependent effect.
AICD Decreases Neuron Firing through Enhancement of
the Afterhyperpolarization
APs in hippocampal neurons are followed by a post-burst after-
hyperpolarization potential (AHP) (Sah, 1996; Storm, 1990). The
AHP is critical for the control of firing rate (Storm, 1990). There-
fore, we hypothesized that AICD could alter neuronal intrinsic
excitability through AHP enhancement. As AHP size is related
to AP number during a sustained depolarization (Coulter et al.,
1989), we examined the post-burst AHP elicited by a similar
number of APs at a firing frequency shown to be impaired in
AICD or AICDnls neurons (12 APs at a frequency of 60 Hz; Fig-
ure 2A). We performed the post-burst AHP analysis by consid-
ering its medium (mAHP) (20–100 ms post-burst) and slow
(sAHP) (400 ms to 4 s post-burst) components (Figure 2A), as
both components have been described to affect CA1 neuron
firing activity (Chen et al., 2014; King et al., 2015; Lancaster
and Nicoll, 1987; Madison and Nicoll, 1984; Sah, 1996; Storm,
1990). As shown (Figures 2B and 2C), the mAHP was slightly
enhanced in AICD neurons, becoming statistically significant in
AICDnls neurons, a modification not observed in AICDnes neu-
rons. Also, both sAHP full area and sAHP amplitude were
enhanced in AICDnls neurons (Figures 2D and 2E). A similar result
was obtained upon analysis of post-burst AHP of CA1 pyramidal
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Figure 1. AICD Weakens CA1 Pyramidal Neuron Firing in the Gamma-Frequency Range through a Gene Transcription-Dependent
Mechanism
(A) Diagram shows schematic of in vivo viral transduction protocol.
(B) Photos show low-magnification (34; top panels; scale bars, 200 mm) and high-magnification (360; bottom panels; scale bars, 10 mm) images of CA1 region of
hippocampal slice (left panels show differential interference contrast [DIC] images; right panels showGFP fluorescence) prepared from rat transduced in vivowith
AICDnls.
(C) Protocol used for dissecting the supra-threshold CA1 pyramidal cells properties in the transduced neurons. 200-ms depolarizing current pulses, incrementing
in steps of 50 pA, were applied at a pre-stimulus potential fixed at !65 mV.
(D, F, and H) Mean firing frequency versus injected current summary plot for (D) all tested virus (*p < 0.05, **p < 0.01 AICDnls compared to GFP and AICDnes,
fp < 0.05 AICD compared to GFP and AICDnes; two-way ANOVA with repeated measures); from slices pre-incubated in TAT-scrAICDnls or TAT-AICDnls peptides
(100 nM) for 2 h, alone (F), or in the presence of the gene transcription inhibitor, actinomycin (acti., 25 mM) (H) (*p < 0.05, two-way ANOVAwith repeatedmeasures).
On the right of (D) and (F), samples of AP trains in response to 500-pA current step.
(E and G) Scatter dot plot graphs of spike-frequency adaptation analysis based on the ratio concerning the interval inter stimulus (ISI) observed between the two
last AP and between the two first AP from a train of APs triggered by 500-pA current step, observed on in vivo viral transduced neurons (E) and on neurons from
slices pre-incubated in TAT-scrAICDnls or TAT-AICDnls peptides (100 nM) for 2 h (G).
Each dot in (E) and (G) represents one neuron, also indicated by n value in each panel (**p < 0.01 and ***p < 0.001, one-way ANOVA). Error bars represent the SEM.
Statistic details are fully described in Table S1.
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Figure 2. AICD Decreases Neuron Firing through
Enhancement of the AHP
(A) Protocol used to trigger the AHP. Neurons were
submitted to a depolarization current step sufficient to
induce a train of 12 action potentials at 60 Hz.
(B and F) Examples of traces recorded from (B) trans-
duced neurons or (F) neurons from slices pre-incubated
in TAT-scrAICDnls or TAT-AICDnls peptides (100 nM) for
2 h, with insets where the AHP is presented on an
expanded scale.
(C–E and G–I) Shown are scatter dot plot graphs of AICD-
mediated effect on the mAHP amplitude (C and G), sAHP
area (D and H), and sAHP amplitude (E and I) recorded in
transduced neurons (C–E) or neurons from slices pre-
incubated in TAT-scrAICDnls or TAT-AICDnls peptides
(100 nM) for 2 h (G and H).
Each dot represents one neuron, also indicated by n
value in each panel (*p < 0.05, one-way ANOVA or un-
paired Student t test). Error bars represent the SEM.
Statistic details are fully described in Table S2.
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cells from slices pre-incubated in TAT-AICDnls or TAT-scrAICDnls
peptides (Figures 2F–2I).
SK2 and KCa3.1 Channels Contribute to the AICD-
Mediated Effect on CA1 Neuron Firing Activity
mAHP is highly sensitive to changes in intracellular Ca2+ (Lan-
caster and Zucker, 1994; Storm, 1987; Velumian and Carlen,
1999). In cortical neurons, the mAHP is mediated by small-
conductance Ca2+-activated K+ channels (SK channels) (Villalo-
bos et al., 2004), which are activated by intracellular Ca2+ ions,
with submicromolar Ca2+ affinity (Ko¨hler et al., 1996). In CA1
neurons, however, themAHP is mediated bymultiple ionic chan-
nels, where SK channels do not seem to be the main contributor
(Chen et al., 2014; Gu et al., 2005). As AICD modulates the
resting (Hamid et al., 2007) and evoked (Pousinha et al., 2017)
intracellular calcium levels, we asked whether it could affect
the charge transfer of SK channels, and therefore trigger an
increased contribution of these channels to the mAHP. To test
this hypothesis, we first investigated the effect of apamin, the
SK channel-specific antagonist, on mAHP amplitude. As illus-
trated (Figure 3A), apamin failed to significantly alter the mAHP
generation in GFP neurons. These data show that, physiologi-
cally, the mAHP in CA1 neurons is not mediated by SK channels,
an observation that has previously been reported by others (Gu
et al., 2005), who showed that in these neurons the mAHP is
mediated by a complex of other ionic channels, including Kv7
channels. Interestingly, in the presence of apamin, all trans-
duced neurons displayed an identical mAHP amplitude (Fig-
ure 3A). These data suggest that in the pathological context
(increased AICDnls levels), the SK channel-mediated K+ current
significantly contributes to mAHP amplitude of CA1 excitatory
neurons. In order to investigate whether the SK channel-medi-
ated enhancement of the mAHP in AICDnls could affect neuron
firing activity, we next performed the same protocol used to
study supra-threshold CA1 pyramidal cells properties (200-ms
depolarizing current pulses, incrementing in steps of 50 pA,
applied at a pre-stimulus potential fixed at !65 mV; Figure 1A),
but in the presence of apamin. We focused on AICDnls neurons,
which displayed the most significant increase in the mAHP
amplitude. AP firing analysis showed that the AICDnls firing fre-
quency could be restored to control levels by apamin (100 nM)
at all current injection steps (Figure 3B), strongly suggesting
that SK channels charge transfer is increased in AICDnls neurons.
To corroborate this observation, we accessed the apamin-sensi-
tive current (ISK) of the IAHP. To measure IAHP, neurons were
voltage clamped at !55 mV, and tail currents were evoked
with a depolarizing step to +20 mV for 100 ms followed by a re-
turn to !55 mV (Figure 3C). The ISK component was obtained by
subtraction of the IAHP measured before and after 30 min of apa-
min application. As shown (Figures 3D and 3E), in GFP neurons
the apamin-sensitive component of the IAHP was marginal. By
contrast, the apamin-sensitive somatic current was significantly
increased in AICDnls neurons compared to GFP neurons (Figures
3D and 3E). Since SK channels are sensitive to intracellular cal-
cium levels and we previously reported that AICD enhances
N-methyl-D-aspartate receptor (NMDAR) conductance (Pousi-
nha et al., 2017), we examined whether these receptors could
be the source of Ca2+ leading to SK channels increased perme-
ability. As shown, the NMDAR-selective antagonist (2R)-amino-
5-phosphonovaleric acid (APV) (50 mM) failed to prevent the
increase in ISK observed in AICD
nls neurons (Figure 3E).
Together, these data demonstrate that increased levels of
AICD lead to over-activation of somatic SK channels, through
an NMDAR-independent mechanism.
CA1 pyramidal neurons express the intermediate-conduc-
tance calcium-gated potassium channel KCa3.1, which contrib-
utes to the sAHP (King et al., 2015; Turner et al., 2016). Since
AICD enhances both mAHP and sAHP, it is possible that AICD
not only affects SK channels conductance, but also KCa3.1
channel function. Thus, we evaluated the sAHP amplitude and
the firing excitability in neurons from slices pre-incubated in
TAT-scrAICDnls or TAT-AICDnls in presence of the KCa3.1-selec-
tive inhibitor (TRAM-34). As shown (Figures 3F and 3G), the inhi-
bition of KCa3.1 channels normalizes the sAHP amplitude and
excitability profile of neurons from slices pre-incubated with
TAT-AICDnls, suggesting that these channels also contribute to
the AICD-mediated effect on CA1 neuron firing activity.
The Effect of AICD on Neuron Firing Requires L-type
Ca2+ Channels Activity
We next thought to identify the source of calcium that impacts
SK- and KCa3.1-dependent postburst AHP increase in AICD
neurons, as we previously excluded NMDAR (Figure 3E). We
focused our attention on L-type voltage-dependent Ca2+ chan-
nels because these channels co-localize with SK and KCa3.1
channels in the somatodendritic compartment, with a spatial
proximity that permits rapid regulation of these channels’
conductance during APs (Marrion and Tavalin, 1998; Sahu
et al., 2017). Accordingly, both L-type Ca2+ channel-selective
blockers, nimodipine (5 mM) and isradipine (500 nM), could
restore the firing frequency of neurons pre-incubated in TAT-
AICDnls to control (TAT-scrAICDnls) values at all current injection
steps (Figures 4A and S3A). To test whether AICD-related
enhancement of AHP is due to enhanced L-type Ca2+ influx,
we examined AHP components magnitude in presence of nimo-
dipine or isradipine in neurons pre-incubated with either TAT-
AICDnls or TAT-scrAICDnls. Blocking L-type Ca2+ channels with
either drug prevented the effects of AICD on AHP (Figures 4B,
4C, S3B, and S3C). This indicates that increased AICD expres-
sion leads to an increase of L-type Ca2+ channels permeability,
which stimulates Ca2+-activated channels, namely SK and
KCa3.1 channels, leading to enhanced AHP and, consequently,
to hypoexcitability.
To directly test the influence of AICD on L-type calcium chan-
nels activity, we measured the nimodipine-sensitive current
during a step current injection protocol (Figures 4D and 4E)
in neurons pre-incubated with either TAT-AICDnls or TAT-
scrAICDnls. L-type current magnitude wasmeasured by subtrac-
tion of the selective inhibitor-resistant current from the total
current after perfusion of the antagonist (Figure 4F), confirming
that this current was enhanced by AICDnls.
As SK, KCa3.1, and L-type calcium channel functions are all
affected by AICD, and we show that these AICD modifications
are transcription dependent, we investigated whether AICD
could modify transcription of the genes encoding these chan-
nels. We treated rat hippocampal neuronal cultures (post-natal
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day 16 [P16] to P18) with TAT-scrAICDnls or TAT-AICDnls at a
concentration of 100 nM for 2 h. We collected RNA and per-
formed qPCR for quantification of SK2, KCa3.1, Cav1.2, and
CaV1.3 genes. We did not observe any significant alterations in
the transcription of these genes (Figures S3D–S3F), suggesting
that AICD indirectly modulates their activity by promoting the
transcription of other targets.
In Silico Experiments Predict that Increased AICD
Production in CA1 Pyramidal Cells Impairs
Hippocampus Gamma Oscillations
In order to further support and better explain the ex vivo experi-
mental findings at the cellular level under somatic current injec-
tion, herein described and also recently reported (Pousinha et al.,
2017), we performed in silico experiments. We used a CA1 pyra-
midal cell model previously validated against experimental find-
ings and used to build a network model (Bianchi et al., 2014).
Since this network model was originally based on mouse neuron
properties, we first performed ex vivo whole-cell patch-clamp
recordings in mouse neurons with increased in vivo AICD pro-
duction to confirm that AICD effects on neuron excitability are
species independent. As shown in Figure S4, the effect of
AICD on mouse neuron firing activity is qualitatively similar to
what we have described above in rat.
We optimized the neuron model to reproduce the number of
spikes observed experimentally under control conditions as a
function of a somatic current injection (Figures 5A and 5C). To
reproduce the AICD effects, we found that a 50-fold increase
of the sAHP current and a 60% increase in the L-calcium current
was required in order to reduce the number of spikes as
observed in the experiment. With these parameters, we were
able to obtain a good replication of the experimental profile un-
der the AICD condition (Figures 5B and 5D).
We next tested in silico what would happen in an individual
CA1 pyramidal cell during an in vivo excitatory synaptic activity
in the gamma range (a condition that would be extremely
difficult to carry out experimentally). We carried out a set of sim-
ulations (n = 20) stimulating the neuron with synaptic inputs tar-
geting the distal and proximal dendrites (to model excitatory EC
and CA3 pathways, respectively). The results are shown in
Figure 5E. Under control conditions (Figure 5E, left), the asyn-
chronous activation of the synapses resulted in a tonic firing
behavior at a relatively high frequency. After AICD, under
exactly the same pattern of synaptic activation as in control
(Figure 5E, right), the neurons displayed a much lower excit-
ability, and the tonic firing behavior changed into a bursting ac-
tivity. These effects were caused by the slow dynamics of the
Ca2+-dependent K+ channels.
These results are in agreement with recently reported experi-
mental findings (Pousinha et al., 2017) illustrating that AICD im-
pairs synaptic signal integration when the neuron is stimulated
at frequencies higher than 10 Hz. The power spectrum, obtained
by averaging the somatic traces from 20 simulations (Figures 5F
and 5G), showed that increased AICD production in these neu-
rons can strongly reduce activity in the gamma range (40–
80 Hz) without affecting theta oscillations ("4 Hz). Taken
together, the model results suggest that the AICD-mediated
decrease in CA1 pyramidal cell excitability can significantly
impact hippocampus oscillations during synaptic activity.
In Vivo Production of AICD Elicits Spatial Memory
Encoding Deficits
Hippocampal oscillatory activity has been described as a critical
player in memory encoding, consolidation, and retrieval. We
therefore asked whether animals with increased in vivo AICD
production could present cognitive deficits. SynGFP or synAICD
viruses (Figure S5) were injected bilaterally in dorsal hippocampi
of 21-day-old male rats (Figure 6A). 15 days after in vivo virus
transduction, the rats were subjected to a spatial object recogni-
tion task, which was recently demonstrated to require CA1 pyra-
midal cells gamma activity (Trimper et al., 2017; Zheng et al.,
2016). Briefly, rats were first allowed to freely explore two iden-
tical objects for 5 min in a square arena (sample trial). After
20 min of rest, rats were replaced in the same arena and were al-
lowed to explore the same objects presented before, but one of
the two objects was displaced to a new location (test trial) (Fig-
ure 6B). Notably, synAICD rats showed a significant decrease
in the preference for the object in a new location (Figures 6D
and 6E). AICD-related alterations in locomotor or visual accuracy
can be excluded as both groups (synGFP and synAICD) pre-
sented similar performances in the sample trial (Figure 6C),
average speed (Figure 6F), and distance traveled (Figure 6G).
Also, both groups presented similar thigmotaxis (Figure 6H)
excluding a putative AICD effect on anxiety levels. These results
clearly demonstrate that increased in vivo AICD production in
neurons, in a restricted region of dorsal CA1 hippocampus
of adult rats, is sufficient, per se, to impair spatial memory
encoding.
Figure 3. SK2 and KCa3.1 Channels Contribute to the AICD-Mediated Effect on CA1 Neuron Firing Activity
(A) Scatter dot plot graphs showing that the selective SK channel blocker, apamin (100 nM), prevents AICD-mediated enhancement of mAHP amplitude.
(B) Mean firing frequency versus injected current summary plot for neurons transduced with GFP and AICDnls viruses in absence or presence of apamin (100 nM).
(C) Protocol used to measure the IAHP. Neurons were voltage clamped at !55 mV, and tail currents were evoked with a depolarizing step to +20 mV for 100 ms
followed by a return to !55 mV.
(D) Representative traces of the IAHP, seen as an outward tail current, from GFP and AICD
nls transduced neurons before (black trace) and after (gray trace) bath
application of apamin (100 nM).
(E) Scatter dot plot graph show the subtracted apamin-sensitive current, ISK amplitude (IAHP before apamin perfusion – IAHP after apamin perfusion) observed in
GFP and AICDnls transduced neurons. The NMDAR selective blocker, APV (50 mM) failed to prevent AICDnls effect.
(F and G) Scatter dot plot graph of the sAHP amplitude (F) and mean firing frequency versus injected current summary plot (G) in control condition or presence of
the selective KCA3.1 channel blocker, TRAM-34 (1 mM) for neurons from slices pre-incubated in TAT-scrAICDnls or TAT-AICDnls peptides (100 nM) for 2 h.
Each dot in (A) and (E) and (F) represents one neuron, also indicated by n value in each panel (***p < 0.0001, two-way-ANOVA; *p < 0.05, two-way or one-way
ANOVA). Error bars represent the SEM.
Statistic details are fully described in Table S3.
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Figure 4. The Effect of AICD on Neuron Firing Requires L-type Ca2+ Channel Activity
(A) Mean firing frequency versus injected current summary plot recorded in neurons from slices pre-incubated in TAT-scrAICDnls or TAT-AICDnls peptides
(100 nM) for 2 h, and after recorded in the presence of the L-type Ca2+ channels blocker, nimodipine (5 mM), in the bath perfusion (nim., nimodipine).
(B and C) Scatter dot plot graphs showing (B) mAHP and (C) sAHP amplitude (Vm-Vh, where Vh = !65 mV) recorded from neurons submitted to a depolarization
current step sufficient to induce a train of 12 APs at 60 Hz.
(D) Protocol used to measure the nimodipine-sensitive current. Neurons were voltage clamped at !60 mV, and tail currents were evoked with a hyperpolarizing
step to !100 mV for 100 ms followed by 200-ms depolarizing current pulses, incrementing in steps of 10 pA and return to !60 mV.
(E) I-V plot of whole-cell calcium currents before and after nimodipine (5 mm) application, where I/Imax is the current normalized to themaximal current of each cell.
On the right representative traces of whole-cell calcium current elicited by a voltage step from !100 to +10 mV, before and after nimodipine (5 mm) application.
(F) Scatter dot plot graph shows the subtracted nimodipine-sensitive current in the recorded neurons (*p < 0.05, two-way ANOVA or unpaired Student t test).
Each dot in (B), (C), and (F) represents one neuron, also indicated by n value in each panel. Error bars represent the SEM.
Statistic details are fully described in Table S4.
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DISCUSSION
Here, we provide strong evidence that AICD, at pathological
levels, is a critical trigger for disruption of CA1 neuron firing activ-
ity, alteration of hippocampal network oscillations, and impair-
ment in spatial memory encoding. Notably, we could unravel
the cellular mechanism underlying AICD-mediated hypoexcit-
ability of CA1 pyramidal cells. Briefly, when a neuron with
increased AICD levels receives inputs to fire at high frequency,
an alteration in the L-type Ca2+ channels causes an increased
Ca2+-sensitive AHP, weakening its firing frequency. We showed
evidence that this effect is mediated by Ca2+-activated K+ chan-
nels, namely SK andKCa3.1 channels. Also, in silico experiments
revealed an AICD-mediated alteration of hippocampal network
Figure 5. Computational Model of AICD Ef-
fects
(A and B) Typical traces from somatic current
injections in control (A) and AICD (B) neurons for
I = 0.3 nA under experimental and in silico model
situations.
(C and D) Number of spikes elicited as a function of
the somatic current injection under control (C) or
AICD (D).
(E) Typical traces from in silico synaptic simula-
tions under control (Ctrl) (left) and AICD (right)
conditions.
(F and G) Normalized power spectrum calculated
from 20 simulations under control or AICD condi-
tions for frequencies of 0–150 Hz (F) and same
graph zoomed in for frequencies of 0–15 Hz (G);
lines represent the average and the SEM.
Statistic details are fully described in Table S5.
oscillations, specifically affecting gamma
rhythms. In agreement, animals with
increased AICD levels in the dorsal hippo-
campus failed to recognize a familiar ob-
ject in a novel location, a task that was
recently reported to recruit CA1 pyramidal
neurons firing at gamma frequency
(Trimper et al., 2017; Zheng et al., 2016).
We gathered solid data advocating that
AICD exerts its effect on neuron firing ac-
tivity through a transcription-dependent
mechanism. Besides the fact that AICD
and AICDnls displayed a similar pheno-
type, albeit sometimes more pronounced
in AICDnls neurons, we could prevent
these effects in the presence of a gene
transcription inhibitor, actinomycin, or
by expelling AICD from the nucleus
(AICDnes). Accordingly, AICD is a tran-
scription factor able to modulate tran-
scription of a number of genes (Beckett
et al., 2012; Bukhari et al., 2017; Grimm
et al., 2013; Konietzko, 2012; Pardossi-
Piquard and Checler, 2012) through inter-
action with cofactors/nuclear modulators
(Bukhari et al., 2017; Cupers et al., 2001; Grimmet al., 2013; Kim-
berly et al., 2001).
In agreement with our results, several studies demonstrate
that blocking L-type Ca2+ channels leads to a reduction of the
postburst AHP in hippocampal neurons (Kumar and Foster,
2002), and Santos et al. (2009) reported that expression of
full-length human APP in rat cortical neuron cultures enhances
the AHP, inhibiting calcium oscillations, through a similar
mechanism (L-type Ca2+ channels–Ca2+-activated K+ channels
coupling), that we herein describe. In the past few years, several
authors reported that in CA1 hippocampal neurons, SK channels
play an auxiliary role in controlling the intrinsic excitability of
these neurons (Gu et al., 2005; Chen et al., 2014), barely contrib-
uting to the generation of the mAHP in physiological conditions,
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as we could also observe in GFP neurons. Chen and colleagues
(2014) showed that when the activity of the main contributors to
the mAHP in CA1 neurons, the low-voltage Kv7/M channels, is
compromised, SK channels take charge of reducing spike
output of these neurons. Since our data and the work of Santos
et al. (2009) show a significant contribution of SK channels to the
mAHP in CA1 pyramidal cells, it is plausible to consider that in
pathological conditions the molecular mechanisms underlying
the mAHP generation change. As corollary to enhanced SK
contribution in these conditions, an additional decrease of the
low-voltage Kv7/M channels contribution can thus not be
excluded. Of note, Santos et al. (2009) did not address a putative
APP gene-transcription-dependent mechanism. These results
suggest that increased expression of the full-length APP protein
Figure 6. In Vivo Production of AICD Elicits
Spatial Memory Encoding Deficits
(A) Top: diagram shows schematic of in vivo viral
transduction protocol with AVV injections at P21
and post-behavioral hippocampal transduction
spreading analysis at P40. Bottom: photos show
low-magnification (34) images of CA1 area of
hippocampal slice (left panels show IR-DIC im-
ages; right panels show GFP fluorescence) pre-
pared from rat injected in vivo with synGFP or
synAICD, as indicated.
(B) Diagram illustrating behavioral task to test
hippocampus-dependent spatial memory encod-
ing, adapted from Zheng et al. (2016), in synGFP
and synAICD rats.
(C and D) Scatter dot plot graphs representing: (C)
total object exploration during sample trial and (D)
time of exploration during the test trial, where one
of the objects is presented in a new location (dis-
placed) (*p < 0.05, two-way ANOVA).
(E) Discrimination index (**p < 0.01, one-sample
Student’s t test).
(F) Average speed during the test trial.
(G) Distance traveled per bins of 1 min during test
trial.
(H) Thigmotaxis during test trial. The blue triangles
(synGFP) and orange triangles (synAICD) corre-
spond to animals (22 and 20, respectively).
Error bars represent the SEM.
Statistic details are fully described in Table S6.
or its C-terminal fragment AICD can
trigger similar signaling cascade of events
to modulate neuronal firing homeostasis.
Indeed, the full-length APP-mediated
inhibitory effect on calcium oscillations
was shown to be dependent on APP-
T668 phosphorylation (Santos et al.,
2011), a residue located in the intracel-
lular domain crucial for the binding of
APP to other intracellular proteins such
as Fe65 or Pin1 (Ando et al., 2001; Pastor-
ino et al., 2006) and known to be impli-
cated in AICD-nuclear signaling (Goodger
et al., 2009; Grimm et al., 2015; Kimberly
et al., 2001).
Conspicuously, an imbalance in AICD levels, and therefore
function, seems to cause detrimental cellular impact by modi-
fying calcium permeability at both synapse and soma. In another
recent study (Pousinha et al., 2017), we demonstrated that, at
synapses, APP deletion leads to the loss of synaptic GluN2B-
NMDARs, a phenotype rescued by AICD delivery; whereas
increasing AICD levels enhances synaptic GluN2B-NMDARs
currents. Accordingly, N2a cells with suppressed levels of
AICD present reduced endoplasmic reticulum (ER) Ca2+ storage
(Hamid et al., 2007), while cells with enhanced levels of AICD
show increased ER Ca2+ filling (Leissring et al., 2002). Intracel-
lular Ca2+ homeostasis greatly relies on the rapid redistribution
of Ca2+ ions into the diverse subcellular organelles, which serve
as Ca2+ stores, including the ER (Brini and Carafoli, 2009;
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Burdakov et al., 2005; Clapham, 1995; Wuytack et al., 2002).
Notably, AICD effects on calcium homeostasis were not
observed when cells were incubated in Ca2+-free medium (Ha-
mid et al., 2007). Together, these previous data and our current
study strongly suggest that AICD effects on Ca2+ homeostasis
are due to alterations in plasmamembrane calcium permeability,
likely involving NMDARs and L-type Ca2+ channels.
Of note, we observed common features in the cellular mech-
anisms underlying the action of AICD in our other recent study,
focused at the synapse (Pousinha et al., 2017), and in the pre-
sent work, focused at the cell body. In both studies, the physio-
pathological actions of AICD are gene-transcription-dependent
and independent of in vivo chronic expression. Moreover, in
both studies, calcium channels present at the plasma mem-
brane are affected by AICD in a frequency-dependent manner.
However, AICD alters NMDAR to modulate synapse function,
whereas it modulates L-type Ca2+ channels to modify firing ho-
meostasis. In both situations, AICD leads to increased calcium
entry, hence rendering the membrane hyperpolarized via Ca2+-
activated K+ channels overactivation. Thus, AICD specifically af-
fects calcium channels that are functionally coupled to Ca2+
activated K+ channels in distinct spatial regions of the neuron:
spine and cell body (Ko¨hler et al., 1996; Marrion and Tavalin,
1998). Overall, it is plausible to advocate that AICD synaptic
and somatic effects perturb neuron homeostatic machinery,
tuning down the sensitivity of CA1 excitatory neurons to the
incoming inputs, reducing its chance to participate in a given
memory trace.
The mean firing rate, reflecting an average level of sponta-
neous spiking activity, is under homeostatic control in central
neural circuits, as recently demonstrated in both ex vivo (Slomo-
witz et al., 2015) and in vivo (Hengen et al., 2016) models. Thus,
homeostatic mechanisms stabilize neural circuit function by
keeping firing rates within a set-point range, by, for example,
adjusting the Ca2+-sensitive AHP, which is critical for the control
of neuron firing activity (Storm, 1990). All transmembrane cur-
rents contribute to brain rhythms, in particular Na+ currents
that are generated by APs (Buzsa´ki et al., 2012). We could
show, through in silico modeling, that increased AICD produc-
tion in CA1 pyramidal cells can strongly reduce their activity
within the gamma-rhythm range (40–80 Hz) without affecting
theta oscillations ("4 Hz). These results are in agreement with
our original hypothesis: that increased levels of AICD cause
CA1 pyramidal cells hypoactivity specifically at inputs of high fre-
quency. Gamma oscillations have been attributed to various
cognitive processes including hippocampus memory encoding
(Lisman and Idiart, 1995; Zheng et al., 2016). Notably, we now
show that increased AICD production in a restricted area of dor-
sal hippocampus is sufficient to impair object recognition in a
novel location, a task recently attributed to CA1 place cell firing
at gamma frequency (Zheng et al., 2016), thus suggesting a cau-
sality between AICD-associated CA1 pyramidal cells decreased
firing and hippocampal cognitive deficits.
Both physiological aging and AD comprehend functional and
structural alterations in the hippocampus that drive cognitive
decline. Therefore, it is conceivable to hypothesize that the shift
from normal aging to AD could be related to common patho-
physiological events, which become exacerbated in the neuro-
degenerative disorder. Intriguingly, our results highly correlate
with observations reported in CA1 neurons from aged rodents.
One of the well-characterized markers of physiological aging is
an age-related decrease in AP firing rates of CA1 pyramidal cells,
Figure 7. Emerging Model for AICD Patho-
logical Effects on Neuronal Function
(A and B) Here, we show two comparative panels
illustrating two scenarios: physiology (A) and pa-
thology due to increased levels of AICD (B). As
indicated in (B), when AICD levels are increased to
pathological levels, it acts both at the spines (3 to 8)
and at the soma (9 to 14), changing the sensitivity
of the neuron to the inputs. AICD translocates to
the nucleus (1), where it modulates gene tran-
scription (2) through yet-unknown mechanisms. At
the synapse (as reported in Pousinha et al., 2017),
increased AICD leads to NMDAR conductance
upregulation (3), leading to increased Ca2+
permeability (4), which in turn activates the nearby
Ca2+ activated K+ channels (5). These channels are
K+ permeable, causing a hyperpolarization of the
cell membrane (6), hence inhibiting NMDA re-
ceptors (7) and, consequently, perturbing synaptic
signal integration (8). At the soma, pathological
levels of AICD trigger increased Ca2+ permeability
through L-type Ca2+ channels (9, 10), thus leading
to close-by Ca2+-activated K+ channels opening
(11). As K+ exits the cell, the membrane becomes
hyperpolarized (12), producing an increased Ca2+-
sensitive AHP (13), thus decreasing neuron firing
activity (14). Together, these mechanisms contribute to neuron firing homeostasis failure, in particular at high frequencies, thus impairing the signal output and
therefore the associated memory processes. The increase in ionic channel numbers in the physiopathological condition is for graphical purposes only as we do
not at present hold evidence for any AICD-induced increase in cell surface expression of these channels.
Cell Reports 29, 317–331, October 8, 2019 327
with a concomitant increase in the amplitude of the AHP respon-
sible for spike frequency adaptation (Disterhoft et al., 1996;
Landfield and Pitler, 1984; Power et al., 2002). Moreover,
although the molecular mechanisms responsible for these alter-
ations in aging brains are still not fully understood, several
studies suggest that it is due to L-type calcium channels dysre-
gulation. Indeed, their charge transfer is enhanced in aged hip-
pocampal neurons (Nu´n˜ez-Santana et al., 2014; Veng et al.,
2003), and their antagonists can counteract the effects of aging
on cognition (Rose et al., 2007; Veng et al., 2003). A provocative
interpretationmay arise from these similarities: AICD age-related
progressive upregulation, likely due to either a lower degradation
rate linked to reduced expression of its insulin-degrading
enzyme (Cook et al., 2003; Nalivaeva and Turner, 2017) or
increased production triggered by BACE1 enhanced expression
(Ahmed et al., 2010; Holsinger et al., 2002), may contribute to the
shift from physiological aging to AD.
Our observations extend the knowledge on AICD pathological
role strengthening its contribution to AD pathogenesis. Although
more work is needed to understand precisely the nuclear AICD
targets/mechanisms that modify membrane calcium channel
permeability, we propose an emerging model based on our
recent work (Pousinha et al., 2017) and the results herein
described (Figure 7). Increased AICD levels lead to enhanced
membrane calcium permeability through synaptic GluN2B-
NMDAR and somatic L-type Ca2+ channels, which activate the
nearby Ca2+-activated K+ channels, rendering the neuron hypo-
active. Thus, AICD decreases neuron sensitivity to excitatory
synaptic inputs and, simultaneously, reduces its ability to fire
at gamma frequency when solicited. Together, these AICD-trig-
gered modifications will impede normal neuron responses to
experience-driven stimuli, hence impairing the underlying mem-
ory tasks, like spatial memory encoding. More broadly, the cur-
rent findings highlight common features between physiological
aging and AD, thus suggesting that AICD might correlate with
progressive neuron homeostatic failure, driving the transition
from synaptic and cognitive impairments, observed in physiolog-
ical aging, to neurodegeneration.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, Peptides, and Recombinant Proteins
TAT-AICDnls: YGRKKRRQRRRVMLKKKQYT SIHHGVVEVDAA
VTPEERHLSKMQQNGYENPTYKFFEQMQNPKKKRKV
PSL GmbH (Heidelberg,
Germany)
N/A
TAT-scrAICDnls: YGRKKRRQRRRVQGITQKMYHNQEGKF
LNQKVNVKTHMQFEHETLVDSMKAYYRVEEPSAPKKKRKV
PSL GmbH (Heidelberg,
Germany)
N/A
Actinomycin Sigma Cat#A9415
Apamin Calbiochem CAS 24345-16-2
TRAM-34 Abcam Cat# ab141885
D-APV Abcam Cat# ab120003
TTX Abcam Cat# ab120055
nimodipine Abcam Cat# ab120138
Isradipine Abcam Cat# ab120142
Critical Commercial Assays
RNeasy Plus Mini Kit QIAGEN, Germany Cat# 74134
SuperScript First-Strand Synthesis System Invitrogen, USA Cat# 18091050
Power SYBR Green PCR Master Mix Applied Biosystems, UK Cat#1725095
Deposited Data
CA1 pyramidal neuron model Bianchi et al., 2014 ModelDB acc.n.151126
All models and simulation files for this paper This paper https://senselab.med.yale.
edu/ModelDB, acc.n. 256388
Experimental Models: Cell Lines
AAV-293 cells Agilent Technologies, USA RRID:CVCL_6871
Experimental Models: Organisms/Strains
Rat: Sprague Dawley Janvier Labs, France RRID:RGD:5508397
Mouse: C57BL/6JRj Janvier Labs, France RRID:MGI:5752053
Oligonucleotides
PPIA peptidylprolyl isomerase A (cyclophilin A)
Forward Primer: ATCTGCACTGCCAAGACTGAGTG
Invitrogen, USA N/A
PPIA peptidylprolyl isomerase A (cyclophilin A)
Reverse Primer: CTTCTTGCTGGTCTTGCCATTCC
Invitrogen, USA N/A
Ribosomal protein L13A
Forward Primer: GGATCCCTCCACCCTATGACA
Invitrogen, USA N/A
Ribosomal protein L13A
Reverse Primer: CTGGTACTTCCACCCGACCTC
Invitrogen, USA N/A
Potassium Calcium-Activated Channel Subfamily N Member 2
Forward Primer: TATGCGCTCATCTTCGGCAT
Invitrogen, USA N/A
Potassium Calcium-Activated Channel Subfamily N Member 2
Reverse Primer: AGAATACAGCGACGCCTTGT
Invitrogen, USA N/A
Potassium Calcium-Activated Channel Subfamily N Member 4
Forward Primer: AGTGTTTAATCACGCTGTCCACT
Invitrogen, USA N/A
Potassium Calcium-Activated Channel Subfamily N Member 4
Reverse Primer: CCCGTTGTCAGTCATGAACA
Invitrogen, USA N/A
Calcium voltage-gated channel subunit alpha1 C
Forward Primer: TGCCTCCGAACACTACAACC
Invitrogen, USA N/A
Calcium voltage-gated channel subunit alpha1 C
Reverse Primer: CCCCGCACACAATGAAACAG
Invitrogen, USA N/A
(Continued on next page)
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Paula A.
Pousinha (pousinha@ipmc.cnrs.fr).
Some Plasmids used in this study are available in Addgene [pAAV-AICD-NLS-IRES-hrGFP, Addgene: #107543; pAAV-AICD-NES-
IRES-hrGFP, Addgene: #107544; pAAV-syn-IRES-hrGFP, Addgene: #107549; pAAV-syn-AICD-IRES-hrGFP, Addgene: #107548].
All unique/stable reagents generated in this study are available from the Lead Contact without restriction.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Sprague Dawleymale rats (RRID:RGD_5508397) (Janvier Labs, France) were used at post-natal days (PND) 21-30. Male C57BL/6JRj
mice (Janvier Labs, France) were used at 8-12 weeks of age. All experiments were done according to policies on the care and use of
laboratory animals of EuropeanCommunities Council Directive (2010/63). The protocols were approved by the FrenchResearchMin-
istry following evaluation by a specialized ethics committee (protocol number 00973.02 and 00468.03). All efforts were made to mini-
mize animal suffering and reduce the number of animals used. The animals were housed three per cage under controlled laboratory
conditions with a 12-h dark light cycle, a temperature of 22 ± 2#C. Animals had free access to standard rodent diet and tap water.
Primary neuronal cultures
Cortical and hippocampal neurons were cultured from 18 day Sprague Dawley rat embryos (Harlan, Barcelona, Spain) as previously
described (Valadas et al., 2012). Briefly, embryos were collected in Hank’s Balanced Salt Solution (HBSS, Corning, USA) and rapidly
decapitated. Meninges were removed, and whole cortices (hippocampi and attached cortex) were dissociated and incubated for
15 min in HBSS with 0.025% trypsin. Cells were washed once with HBSS with 30% Fetal Bovine Serum (FBS), centrifuged three
times, re-suspended in Neurobasal Medium (GIBCO – Life Technologies, USA) supplemented with 2% B-27 supplement, 25 mM
Glutamate, 0.5 mM glutamine, and 2 U/ml Penicillin/Streptomycin, gently dissociated and filtered through a 70 mm strainer (VWR,
USA). Cells were plated on poly-D-lysine-coated plates and grown for 14 days at 37#C in a 5% CO2-humidified atmosphere in
the previously described supplemented Neurobasal medium, in the absence of any positive selection for neurons. Day 12-14, neu-
rons were treated with TAT-scrAICDnls or TAT-AICDnls (100 nM) for 2 h and proceed to RNA extraction.
METHOD DETAILS
Virus Constructs
Virus cloning
c-DNA encoding amethionine followed by the last 50 amino acids of human bAPPwithout or with the SV40 nuclear localization signal
(NLS; PKKKRKV) or the HIV-1 Rev nuclear export signal (NES: LPPLERLTL) attached to its C-terminal end, called AICD and AICDnls
and AICDnes respectively, were inserted into the multiple cloning site (MCS) of the pAAV-IRES-hrGFP vector (Agilent Technologies,
USA) by standard PCR cloning. Empty pAAV-IRES-hrGFP vector expressing only GFP was used as control (referred to as GFP virus)
(Pousinha et al., 2017). High titer synGFP and synAICD viruses were constructed using the backbone vector pAAV-syn-GFP (Addg-
ene plasmid #58867). In this vector, the GFP cDNA was replaced by either the hrGFP or the AICD-IRES-hrGFP using standard PCR
cloning.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Recombinant DNA
AAV helper DNA: pH21 Hauck et al., 2003 N/A
AAV helper DNA: pRV1 Hauck et al., 2003 N/A
AAV helper DNA: pF6 Hauck et al., 2003 N/A
pAAV-IRES-hrGFP Agilent Technologies, USA Cat#240075
pAAV-AICD-IRES-hrGFP Pousinha et al., 2017 N/A
pAAV-AICD-NLS-IRES-hrGFP Pousinha et al., 2017 Addgene: #107543
pAAV-AICD-NES-IRES-hrGFP Pousinha et al., 2017 Addgene: #107544
pAAV-syn-IRES-hrGFP Pousinha et al., 2017 Addgene: #107549
pAAV-syn-AICD-IRES-hrGFP Pousinha et al., 2017 Addgene: #107548
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Virus Production
GFP, AICD, AICDnls and AICDnes recombinant AAV virions, all expressing hrGFP, were produced essentially as described previously
(Hauck et al., 2003; Pousinha et al., 2017). Briefly, to produce rAAV virions containing 1:1 ratio of type 1 and type 2 capsid proteins,
AAV-293 cells (Agilent Technologies, USA) were co-transfected with the GFP, AICD, AICDnls, AICDnes plasmid and three helper
plasmids (pH21, pRV1 and pF6) using the calcium phosphate method. 65 h post-transfection, the cells were harvested, rAAVs
were purified using 1 mL HiTrap heparin columns (Sigma-Aldrich, France) and concentrated using Amicon Ultra centrifugal filter de-
vices (Millipore, USA). The concentrated viral solution was aliquoted and stored at !80#C until further use. Titer quantification was
performed in HT1080 cells as described by Agilent Technologies. We consistently obtained titers of"53 108 particles/ml for viruses
for viruses exhibiting low transduction efficiency (GFP, AICD, AICDnls, AICDnes) and "5 3 1012 particles/ml for viruses with high
transduction efficiency (synGFP and synAICD).
TAT peptides
TAT-scrAICDnls and TAT-AICDnls were synthesized by PSL GmbH (Heidelberg, Germany). TAT-AICDnls contained the TAT
sequence (YGRKKRRQRRR), conferring cell permeability, fused to the N-terminal of AICD:
MLKKKQYTSIHHGVVEVDAAVTPEERHLSKMQQNGYENPTYKFFEQMQN. The SV40 nuclear localization signal (NLS; PKKKRKV)
was added to the AICD C-terminal for nuclear translocation. The TAT-scr AICDnls contained the same TAT and NLS sequences at
each end of a scrambled version of the AICD sequence: VQGITQKMYHNQEGKFLNQKVNVKTHMQFEHETLVDSMKAYYRVEEPSPA.
The purity of peptides was above 90%–95%.
In Vivo AAV Injections
PND21-22 Sprague Dawley male rats (50-70 g) were anesthetized with a mixture of ketamine (0.2 mg/g body weight) and xylazine
(0.04 mg/g body weight) by intraperitoneal injection. Local analgesia was increased by injecting 35-40 ml of lidocaine (diluted at
0.5%) at site of incision. After immobilization on a stereotaxic instrument, a hole per hemisphere side was drilled (1-2 mm diameter)
at!4 mm posterior and ± 2.5 mm lateral to bregma for injection in the CA1 region of the hippocampus. Using a stainless steel canula
at a depth of 2.6 mm, viral solution (1 ml) was injected with a Harvard Apparatus pump at a flow rate of 0.2 ml/min. Rats were sutured
and Ketofen (diluted in the bottle of water, 5mg/L) was administrated during the first 24h after surgery to ease post-operative pain.
C57BL/6JRj mice of 8 weeks’ old were injected with either synGFP AAV and synAICD AAV in both dorsal hippocampi. Stereotaxic
injections were performed using a stereotaxic frame (Kopf Instruments) under general anesthesia with xylazine and ketamine
(10 mg/kg and 150 mg/kg, respectively). 500nl of synGFP or synAICD were injected in each hippocampus with an injection rate
set at 100nl/min. Coordinates for dorsal hippocampus were adjusted from Paxinos and Watson (AP: !2,2, ML ± 1,5, DV !1,4). After
injection, animals were stitched and a 3 weeks’ recovery period were given to allow sufficient viral expression.
Quantitative PCR in primary neuronal cultures
RNA extraction and quantitative real-time PCR analysis (RT-qPCR): Total RNAwas extracted and purified using the RNeasy PlusMini
Kit (QIAGEN, Germany). RNA quality was assessed by NanoDrop 2000 (Thermo Scientific, USA) analysis (A260/A280z2; 260/235 >
1.8). Total RNA (2 mg) was reverse-transcribed using random primers and SuperScript First-Strand Synthesis System for RT-PCR
(Invitrogen, USA). RT-qPCR analysis was performed on a Corbett Rotor-gene 6000 apparatus (QIAGEN, Germany) using Power
SYBR Green PCR Master Mix (Applied Biosystems, UK), 0.2 mM of each primer and 1/20 dilutions of total cDNA (final concentration
0.4 ng/ml). The thermal cycler conditions were 10 min at 95#C, 40 cycles of a two-step PCR, 95#C for 15 s followed by 60#C for 25 s
with a final thermal ramp from 72 to 95#C. Primer efficiencies (E = 1 ± 0.02) were obtained from standard curves of serial dilutions
(slope and R2 respectively around !3.3 and 0.99). Sequences of primers used (all from Invitrogen, UK, HPLC purified) are listed
in Figure S3. Reference genes were PPIA (cyclophilin A) and Rpl13A (ribosomal protein L13A). Amplifications were carried out in trip-
licate in two independent runs, and according to theMIQE guidelines (Bustin et al., 2009). The relative expression of target genes was
determined by the comparative CT method (Schmittgen and Livak, 2008).
Pharmacological tools
Different pharmacological tools were used: Actinomycin (Sigma Aldrich, France) to inhibit gene transcription, Apamin (Calbiochem,
France) to block SK channels, TRAM-34 to block KCa3.1 channels (Abcam, France); D-AP5 (abcam, France) to block NMDA recep-
tors, TTX (abcam, France) to block voltage-gated Na+ channels, nimodipine (abcam, France) and Isradipine (Abcam, France) to block
L-type Ca2+ channels.
Patch-Clamp Electrophysiology
Electrophysiological recordings were done on rats or mice 12-20 days after in vivo viral injections or on naive rats (PND32-40). Acute
transverse hippocampal slices (250 mm thick) were prepared using standard procedures (Marie et al., 2005), resumed in the
Supplement.
Slices were visualized on an uprightmicroscope with IR-DIC illumination and epi-fluorescence (Scientifica, Ltd).Whole-cell record-
ings were performed using a Multiclamp 700B (Molecular Devices) amplifier, under the control of pClamp10 software (Molecular
Devices).
e3 Cell Reports 29, 317–331.e1–e5, October 8, 2019
After a tight seal (> 1GU) on the cell body of the selected neuron was obtained, whole-cell patch clamp configuration was estab-
lished, and cells were left to stabilize for 2-3 min before recordings began. Holding current and series resistance were continuously
monitored throughout the experiment, and if either of these two parameters varied bymore than 20%, the experiment was discarded.
Brain slices preparation
Briefly, rats were anaesthized with isoflurane and decapitated. Hippocampi were quickly removed. slices were cut on a vibratome
(Microm HM600V, Thermo Scientific) in ice-cold dissecting solution containing (in mM): 234 sucrose, 2.5 KCl, 0.5 CaCl2, 10
MgCl2, 26 NaHCO3, 1.25 NaH2PO4 and 11 D-glucose, oxygenated with 95% O2 and 5% CO2, pH 7.4. Slices were first incubated,
for 60min at 37#C, in an artificial CSF (aCSF) solution containing (inmM): 119 NaCl, 2.5 KCl, 1.25 NaH2PO4, 26 NaHCO3, 1.3MgSO4,
2.5 CaCl2 and 11 D-glucose, oxygenated with 95%O2 and 5%CO2, pH 7.4. Slices were used after recovering for another 30 min at
room temperature. For all experiments, slices were perfused with the oxygenated aCSF at 31 ± 1#C. In the case of AICD ex-vivo de-
livery, sliceswere pre-incubated in TAT peptides for 2h to 5h. Control (scramble AICD) and TAT-AICD peptideswere tested in parallel.
Recording pipettes (5-6 MU) for voltage-clamp experiments were filled with a solution containing the following (in mM): 117.5 Cs-glu-
conate, 15.5 CsCl, 10 TEACl, 8 NaCl, 10 HEPES, 0.25 EGTA, 4 MgATP and 0.3 NaGTP (pH 7.3; osmolarity 290-300 mOsm). For cur-
rent-clamp experiments, the recording pipette solution contained (in mM): 135 gluconic acid (potassium salt: K-gluconate), 5 NaCl, 2
MgCl2, 10 HEPES, 0.5 EGTA, 2 MgATP and 0.4 NaGTP (pH 7.25; osmolarity 280-290 mOsm).
Electrophysiology Protocols
The resting membrane potential (Vm) was first measured in the absence of any spontaneous firing, and only cells more negative than
!55mVwere considered. Themembrane resistance was obtained by clamping neurons at Vh =!60mV, injecting!200pA of current
(500ms duration), measuring the amount of steady-state hyperpolarization and calculating the resistance value by Ohm’s law
(Figure S1).
To study the relationship between firing frequency and current input (e.g., Figures 1D and 1F), we first adjusted the membrane po-
tential (Vh) to !65 mV and then injected pulses of increased intensity in steps of 50 pA (from 100 to 600 pA, 200 ms duration). In the
case of pharmacological studies on neuron firing frequency (Figures 1H, 3B, 3G, 4A, and S3A), drugs were added to the perfusion
bath at least 30 min before recordings.
The involvement of Na+ channels in spike generation was derived from ‘‘phase-plane’’ plot obtained by drawing the first time de-
rivative of voltage (dV/dt) versus voltage (Figure S2). We could thus estimate the amount of transient Na+ current contributing to the
spike up-stroke from the maximal value of dV/dt (dV/dtmax) and the spike threshold as the voltage at which dV/dt was 4% of dV/
dtmax (Bean, 2007).We restricted the analysis of Na+ channel availability in spike generation by considering only the action potentials
(APs) generated at I = 500pA, a current step inducing a significant difference in the firing frequency between AICD neurons and
respective controls.
We measured the spike-frequency adaptation for I = 500pA as the ratio between the ratio between the last AP inter-stimulus in-
terval (ISI) and the first AP ISI (Figure 1E).
AHPs were triggered by a high-frequency train of APs that consisted of 12 APs at 60Hz and were reported as an average of 2
sweeps per cell. The mAHP amplitude was defined as the difference between the membrane potential at the beginning (before
cell depolarization) and the peak negative value 20 – 100 ms following the train of APs (Figure 2A). The sAHP amplitude was defined
as the as the difference between the membrane potential at the beginning (before cell depolarization) and the peak negative value at
400ms following the train of APs. The sAHP area was defined as the area within 400ms to 4 s following the train of APs.
For measurement of the IAHP, TTX was added to the bath solution. Neurons were voltage clamped at !55 mV, and tail currents
were evoked with a depolarizing step to +20mV for 100ms followed by a return to!55mV (Hammond et al., 2006) (Figure 3C). After a
stable line was established, apamin (100nM) was applied to the bath. The apamin sensitive current (ISK) was obtained by subtraction
of the IAHP obtained before and after 30 min of apamin application (Figures 3D and 3E).
For mesurements of the nimodipine-sensitive currents, TTX and Picrotoxin were added to the bath solution. Neurons were voltage
clamped at!60 mV, and tail currents were evoked with a hyperpolarizing step to!100 mV for 100ms followed by 200 ms depolariz-
ing current pulses, incrementing in steps of 10pA and return to!60mV. The nimodipine sensitive current was obtained by subtraction
of the current obtained before and 30 min after nimodipine application (Figures 4D–4F).
In silico modeling
All simulations were carried out using the NEURON environment (v7.6, Hines and Carnevale 2003) and a CA1 pyramidal neuron im-
plemented with the simplified 15-compartments morphology taken from Bianchi et al. (2014) (ModelDB acc.n.151126). All models
and simulation files will be uploaded to the public ModelDB database (https://senselab.med.yale.edu/ModelDB, acc.n. 256388).
The model neuron included Hodgkin-Huxley type currents (axon and somadendritic, Na+ and Kdr), two A-type potassium current
(proximal and distal dendrites), one M-type potassium current, a h-current, three types of voltage dependent calcium currents (CaL,
CaT, CaR), two types of calcium dependent potassium current (a slow AHP and a medium AHP current) and a calcium pump. The
channel peak conductances and the dendrites diameters and lengths weremodified from their original values (tuned to be consistent
with recordings in mice), to take into account the specific set of experimental recordings in mice used in this work. We implemented
two main excitatory synaptic afferent pathways, as in Bianchi et al. (2014): one mimiking EC inputs (20 AMPA synapses, each one
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with a peak conductance of 1.45nS) and another one modeling CA3 Schaffer collateral inputs (20 AMPA and NMDA synapses, with
peak conductances 1.45 and 0.5nS, respectively). Each synapse was independently activated according to a Poisson distribution, at
an average frequency of 40 Hz (in the g range).
Behavioral analysis
42 Sprague Dawley male rats were tested in a spatial object recognition task at P32, 15 days after in vivo virus transduction by ste-
reotaxic surgery.
Experiments were performed during day (9h-18h). A plexiglass square openfield of 60 cmwith cues on the wall was used. Linoleum
was placed on the floor. Objects for Sample and Test were similar (plastic, "15 cm high and "10 cm large). The floor was cleaned
with 10% ethanol solution and rinse with water between each trial. The intensity of the light was set at 4 lux to minimize anxiety. We
adapted a behavioral protocol that was previously described to test spatial memory (Zheng et al., 2016), which consisted of two trials
with 5min duration with 20min inter-trial interval (ITI). First, rats were allowed to freely explore the apparatus for two consecutive days
during 5min (Habituation). Then, rats were submitted to a Pre-training, where two different objects, which were not reused in the test
day, were placed in the arena in a constant location, to minimize neophobia. On the Test day, animals were allowed to explore two
new identical objects in a first trial (Sample Trial). After the 20 min ITI, for the Test trial, the same objects were presented, but one
object was presented in a new location (Displaced object), while the other object remained in its previous location (Non-displaced
object). Object configurations for Sample and Test trials were counter-balanced. Experiments and analysis were done blind as to
condition (SynGFP- or synAICD transduced rats). Object exploration was scored only when the animal was facing an object, with
its nose within 1 cm of the object. Moments when the rat was touching the object with another part of the body, or when leaning
or rearing on the object were not scored as object exploration. For the Test trial, a discrimination index was calculated: [time spent
exploring object in the novel location]/[ total objects exploring time]. The index value is "0.5 (chance value) if the animal does not
show any object preference, spending similar time exploring each object. The trajectory of the animals was video recorded and
tracked with ANYmaze software (Stoelting, Wood Dale, USA). The total distance traveled (presented as 1 min bins) and average
speeds during Test trial were counted as measures of locomotor activity. The analysis of thigmotaxis, a measure of anxiety, was
calculated as the time spent in center compared to the time spent in the periphery of the apparatus. At the end of the behavioral ex-
periments, all brains were dissected and correct targeting of the hippocampus was verified (GFP fluorescence). Two AICD injected
rats were removed from the analysis due to misplaced viral injections.
QUANTIFICATION AND STATISTICAL ANALYSES
Results are shown as mean ± SEM ‘n’ refers to the number of cells examined, unless otherwise stated. Statistical significance of
differences between means was determined through Prism 6.0 software (GraphPad) and is presented in details in the Supplement
(Tables S1, S2, S3, S4, S5, and S6). Significance was taken at p < 0.05. the Student’s t test or the Wilcoxon test were performed
whenever two conditions were compared, according to the samples distribution normality. One factor analysis of variance (ANOVA)
was performed to analyze significance among the different conditions. In experiments where mean firing frequency was analyzed as
a function of injected current, a Two-way ANOVA with repeated-measures was applied. In studies where two variables were tested
(e.g., drugs and virus, or behavioral analysis) a Two-way ANOVA was performed. For behavioral analysis, the discrimination index of
each group was compared to chance performance (score of 0.5) using one sample t tests (two-tailed).
DATA AND CODE AVAILABILITY
All simulation and model files are available for public download on the ModelDB repository (acc.n.256388).
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Figure S1 – Related to Figure 1. AICD does not modify neuron passive properties. (A) 
vector maps of the low-transduction efficiency AAV constructs used in this study. AAV 
constructs: AICD, AICDnls or AICDnes were inserted downstream of the CMV promoter and β-
globin intron and upstream of an IRES-GFP sequence. ITR: inverted terminal repeats; P-CMV: 
cytomegalovirus promoter; IRES: internal ribosomal entry site; hrGFP: human recombinant 
green fluorescent protein. (B-C) Scatter dot plot graphs show in (B) the resting membrane 
potential (Vm) and in (C) the membrane resistance (Rm) of transduced neurons. Each dot 
represents one neuron. (D) Protocol used to assess the membrane resistance of CA1 pyramidal 
cells. 200 ms hyperpolarizing current pulses, incremented in steps of -50pA, were applied at a 
pre-stimulus potential fixed at -65 mV. (E) Steady state values of membrane hyperpolarization 
(Vm-Vh, where Vh= -65 mV) plotted vs. the negative current amplitude. On the right, traces of 
voltage responses to hyperpolarizing current step -100pA recorded from neurons transduced 
with the indicated virus. Statistic details are fully described in Supplemental Information Table 
S1. 
 
 
 
  
 
 
 
 
Figure S2 – Related to Figure 1. Na+ channels responsible for AP generation are not 
implicated in the AICD-regulation of neuronal excitability. (A) Example of “Phase-plane 
plots” obtained by plotting dV/dt vs. voltage in a neuron transduced with GFP, considering the 
first and last APs of the train spike from trace shown in Figure 1E. (B) Scatter dot plot graphs 
show in (B) the dV/dtmax calculated from the “Phase plane plots” obtained from the AP trains 
induced by 500pA current step and in (C) the spike threshold values taken as 4% of dV/dtmax. 
Each dot in (B) and (C) represents one neuron. Statistic details are fully described in 
Supplemental Information Table S1. 
 
 
  
 
 
  
Figure S3 – Related to Figure 4. Effect of Isradipine on neuron excitability in control and 
AICD neurons and qPCR experiment to analyze levels of SK2, KCa3.1 and L-type 
calcium channels. (A) Mean firing frequency vs. injected current summary plot recorded in 
neurons from slices pre-incubated in TAT-scrAICDnls and TAT-AICDnls peptides (100nM) for 
2h, and after recorded in the presence of the L-type Ca2+ channels blocker, isradipine (500 nM), 
in the bath perfusion. (B) and (C) Scatter dot plot graphs showing (B) mAHP and (C) sAHP 
amplitude (Vm-Vh, where Vh=-65mV) recorded from neurons submitted to a depolarization 
current step sufficient to induce a train of 12 APs at 60Hz. (D) Characterization of hippocampal 
primary neuronal cultures (15 days in vitro; MAP2 (neuronal marker), GFAP (astrocytic maker) 
and cell nuclei (scale bar - 50 μm), used to evaluate the effect of AICD on the transcription of 
putative targets: (E) qPCR results on genes coding for SK2 (KCCN2), KCa3.1 (KCNN4), 
CaV1.2 (Cancna1c) and CaV1.3 (Cacna1d) channels comparing control (TAT-scrAICDnls) and 
treated (TAT-AICDnsl) neurons. (F) Details of primers used for qPCR. (*P<0.05, Two-way 
ANOVA or Unpaired student-t Test). Each dot in (B) and (C) represents one neuron. Statistic 
details are fully described in Supplemental Information Table S4. 
Figure S4 – Related to Figure 5. Comparison of AICD effect on neuron firing activity observed 
in the different experimental models. (A) Photos show representative images of coronal brain slices 
prepared from mice injected in vivo with synGFP and synAICD, as indicated. GFP and DAPI (nuclear 
marker). Images were acquired on the FV10 Olympus confocal microscope with automatized stitching. 
Scale bars 500 m. (B) Mean firing frequency vs. injected current summary plot recorded in neurons 
from mouse slices pre-incubated in TAT-scrAICDnls and TAT-AICDnls peptides (100nM) for 2h. (C) 
Bars graph showing AICD effects on neuron firing frequency observed in the different models. Statistic 
details are fully described in Supplemental Information Table S5.
  
 
Figure S5 – Related to Figure 5 and 6. High titer SynAICD and SynGFP AAV constructs 
 Diagrams of AAV constructs representing SynGFP and SynAICD viruses, which exhibit 
specific expression of AICD in neurons with high transduction efficiencies. AICD was inserted 
downstream of the synapsin promoter and upstream of the hrGFP sequence via an IRES linker. 
ITR: inverted terminal repeats; P-SYN: synapsin promoter; IRES: internal ribosomal entry site; 
hrGFP: human recombinant green fluorescent protein; WPRE: Woodchuck Hepatitis Virus 
Post-transcriptional Regulatory Element. 
 
